NEKTAR THERAPEUTICS (NKTR) Stock Income Statement
NASDAQ:NKTR - Nasdaq - US6402681083 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 87.25M | 98.43M | 90.12M | 92.10M | 101.90M | |||
| Cost Of Goods | 22.15M | 30.69M | 33.77M | 21.60M | 24.90M | |||
| Gross Profit | 65.10M | 67.74M | 56.35M | 70.40M | 77.00M | |||
| Operating Expenses | 204.93M | 197.66M | 191.58M | 310.70M | 523.10M | |||
| Research and Development | 123.98M | 120.91M | 114.16M | 218.30M | 400.30M | |||
| Selling, General, and Administrative Expenses | 80.95M | 76.75M | 77.42M | 92.30M | 122.80M | |||
| Operating Income | -139.83M | -129.92M | -135.22M | -240.30M | -446.10M | |||
| Interest Income/Expense | -14.40M | -13.61M | -6.33M | 11.20M | -52.80M | |||
| Other Income/Expense | -25.00K | -390.00K | -6.25M | 0.00 | -24.40M | |||
| Non Recurring Items | 25.53M | 24.72M | -128.46M | -135.90M | 0.00 | |||
| Income Before Taxes | -128.73M | -119.20M | -276.26M | -365.00M | -523.30M | |||
| Income Tax | -152.00K | -239.00K | -200.00K | 3.20M | 600.00K | |||
| Net Income | -133.04M | -118.96M | -276.06M | -368.20M | -523.80M | |||
| EBITDA | -136.62M | -125.53M | -127.41M | -227.30M | -432.00M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.63 | -0.58 | -1.45 | -1.97 | -2.86 | |||
| Non GAAP EPS | -0.83 | -0.78 | -1.05 | -1.97 | -2.85 | |||
| Statistics | ||||||||
| Gross Profit Margin | 74.61% | 68.82% | 62.53% | 76.44% | 75.56% | |||
| Profit Margin | -152.49% | -120.86% | -306.31% | -399.78% | -514.03% | |||
| Operating Profit Margin | -160.27% | -131.99% | -150.05% | -260.91% | -437.78% | |||
All data in USD